Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Sex Abuse ; 13(2): 91-103, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11294127

ABSTRACT

To date, there has been limited literature on the measurement of sexual arousal in adolescent sex offenders. The data that exist have been somewhat mixed in terms of factors related to deviant sexual arousal in this group. The present study, with 71 adolescent sex offenders, investigates the relationship between offender and offense characteristics, including gender of victim, history of sexual abuse, history of physical abuse, race, and interactions between these factors in the prediction of physiologically measured sexual arousal to deviant and nondeviant stimulus categories. A number of variables significantly predicted sexual arousal. The most consistent predictors were gender of victim, race, the interaction of race and gender of victim, and to some extent the interaction of offender abuse history and gender of victim. Caucasian subjects tended to respond more than African American subjects did, and this has not been reported previously in the literature. The data are discussed in terms of consistency with other literature, suggesting that those juvenile offenders who target male victims and have been abused themselves may be a high risk group. Limitations of this study are also addressed.


Subject(s)
Arousal/physiology , Juvenile Delinquency/psychology , Juvenile Delinquency/statistics & numerical data , Paraphilic Disorders/diagnosis , Sex Offenses/statistics & numerical data , Adolescent , Adolescent Behavior/psychology , Cues , Factor Analysis, Statistical , Fantasy , Humans , Male , Paraphilic Disorders/epidemiology , Penile Erection/physiology , Sex Factors , Sexual Behavior/psychology
2.
J Urol ; 164(5): 1490-3, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11025689

ABSTRACT

PURPOSE: The optimal method of bladder management in the spinal cord injured population remains controversial. We determined the significance of bladder management and other factors on renal function in this population. MATERIALS AND METHODS: We retrospectively reviewed the medical records and upper tract imaging studies of 308 patients with a mean followup of 18.7 years since injury. Renal function was assessed by serum creatinine, creatinine clearance and proteinuria measurement, and by upper tract abnormalities on renal ultrasound and nuclear medicine renal scan. Independent variables evaluated for an influence on renal function included patient age, interval since injury, injury level and completeness, vesicoureteral reflux, history of diabetes mellitus and bladder management method. RESULTS: Mean serum creatinine plus or minus standard deviation in patients on chronic Foley catheterization, clean intermittent catheterization and spontaneous voiding was 1.08 +/- 0.99, 0.84 +/- 0.23 and 0.97 +/- 0.45 mg./dl. (analysis of variance p = 0.05, Student's t test p = 0.10), and mean creatinine clearance was 91.1 +/- 46.5, 113.4 +/- 39.8 and 115 +/- 49 ml. per minute, respectively (analysis of variance and Student's t test p <0.01), respectively. Proteinuria was present in 19 patients (6.2%) in the Foley catheterization, 3 (1%) in the clean intermittent catheterization and 4 (1.3%) in the spontaneous voiding group (chi-square test p <0.01), while there were upper tract abnormalities in 56 (18.2%), 20 (6.5%) and 24 (7.8%) patients, respectively (chi-square test p <0.01). Multiple regression analyses revealed no significant predictors of serum creatinine, although older patient age and Foley catheterization significantly predicted low creatinine clearance. Additional logistic regression analyses showed that Foley catheterization was associated with proteinuria and vesicoureteral reflux was associated with upper tract abnormalities. CONCLUSIONS: While renal function may be preserved by all forms of bladder management, chronic indwelling catheters may contribute to renal deterioration.


Subject(s)
Kidney/physiopathology , Spinal Cord Injuries/physiopathology , Aged , Catheters, Indwelling/adverse effects , Creatinine/blood , Humans , Logistic Models , Middle Aged , Retrospective Studies , Urinary Catheterization/adverse effects
3.
Arthritis Rheum ; 42(6): 1204-8, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10366113

ABSTRACT

OBJECTIVE: To investigate the efficacy of oral type II collagen (CII) in the treatment of rheumatoid arthritis (RA), when added to existing therapy. METHODS: Patients with active RA (n = 190) were randomized into a 6-month, double-blind, placebo-controlled trial. Patients continued to take their current arthritis medications. Patients received either placebo or bovine CII, 0.1 mg/day for 1 month, then 0.5 mg/day for 5 months. RESULTS: There were no significant differences between the baseline characteristics of either group. The primary response parameter was the American College of Rheumatology (ACR) preliminary definition of improvement in RA (ACR 20). There was no statistically significant difference in the ACR 20 after 6 months (20.0% of placebo patients; 16.84% of bovine CII patients). There were significant differences in several clinical variables after treatment, all favoring the placebo group. CONCLUSION: Oral solubilized bovine CII, added to existing therapy, did not improve disease activity in patients with RA.


Subject(s)
Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Collagen/therapeutic use , Administration, Oral , Adolescent , Adult , Aged , Animals , Arthritis, Rheumatoid/pathology , Cattle , Collagen/administration & dosage , Double-Blind Method , Drug Therapy, Combination , Female , Humans , Joints/drug effects , Joints/pathology , Male , Middle Aged , Pain Measurement , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome
4.
Am J Kidney Dis ; 33(5): 899-903, 1999 May.
Article in English | MEDLINE | ID: mdl-10213646

ABSTRACT

A retrospective, case-control study was performed to investigate the risk factors that may contribute to the development of proteinuria in patients with chronic spinal cord injury (SCI). During an 18-month period, 31 subjects with a 24-hour protein excretion of 1.0 g or greater were identified. Three control subjects with SCIs with a 24-hour urinary protein excretion of less than 1.0 g during the same time period were randomly selected for each study subject with proteinuria. Clinical data, including level and duration of injury, age, presence of indwelling bladder catheter, number of decubitus ulcer procedures, serum albumin and creatinine concentrations, hematocrit, creatinine clearance, and the presence of hypertension and diabetes mellitus, were obtained from medical records. Subjects with proteinuria had other evidence of renal dysfunction with greater serum creatinine concentrations and reduced creatinine clearances, serum albumin concentrations, and hematocrits. Proteinuric subjects were older, had a longer duration of injury, had undergone a greater number of decubitus ulcer procedures, and were more likely to have hypertension and indwelling bladder catheters. The independent predictors for the development of proteinuria using logistic stepwise multiple linear regression analysis were the use of chronic indwelling bladder catheters, number of decubitis ulcer procedures, presence of hypertension, and older age. These data suggest that inflammatory complications associated with complications of chronic SCI, rather than SCI per se, contribute to the development of proteinuria. SCI patients with proteinuria have more impaired renal function and increased mortality compared with SCI patients without proteinuria.


Subject(s)
Proteinuria/etiology , Spinal Cord Injuries/complications , Catheters, Indwelling/adverse effects , Chronic Disease , Demography , Humans , Kidney Failure, Chronic/etiology , Middle Aged , Multivariate Analysis , Pressure Ulcer/complications , Regression Analysis , Retrospective Studies , Risk Factors
5.
Am J Respir Crit Care Med ; 158(6): 1839-47, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9847276

ABSTRACT

We performed a prospective observational cohort study of the epidemiology and etiology of nosocomial pneumonia in 358 medical ICU patients in two university-affiliated hospitals. Protected bronchoscopic techniques (protected specimen brush and bronchoalveolar lavage) were used for diagnosis to minimize misclassification. Risk factors for ventilator-associated pneumonia were identified using multiple logistic regression analysis. Twenty-eight cases of pneumonia occurred in 358 patients for a cumulative incidence of 7.8% and incidence rates of 12.5 cases per 1, 000 patient days and 20.5 cases per 1,000 ventilator days. Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Hemophilus species made up 65% of isolates from the lower respiratory tract, whereas only 12.5% of isolates were enteric gram-negative bacilli. Daily surveillance cultures of the nares, oropharynx, trachea, and stomach demonstrated that tracheal colonization preceded ventilator-associated pneumonia in 93.5%, whereas gastric colonization preceded tracheal colonization for only four of 31 (13%) eventual pathogens. By multiple logistic regression, independent risk factors for ventilator- associated pneumonia were admission serum albumin <= 2.2 g/dl (odds ratio [OR] 5.9; 95% confidence interval [CI] 2.0-17.6; p = 0.0013), maximum positive end-expiratory pressure >= 7.5 cm H2O (OR, 4.6; 95% CI, 1.4 to 15.1; p = 0.012), absence of antibiotic therapy (OR, 6.7; 95% CI, 1.8 to 25.3; p = 0.0054), colonization of the upper respiratory tract by respiratory gram-negative bacilli (OR, 3.4; 95% CI, 1.1 to 10.1; p = 0.028), pack-years of smoking (OR, 2.3 for 50 pack-years; 95% CI, 1. 2 to 4.2; p = 0.012), and duration of mechanical ventilation (OR, 3. 4 for 14 d; 95% CI, 1.5 to 7.8; p = 0.0044). Several of these risk factors for ventilator-associated pneumonia appear amenable to intervention.


Subject(s)
Bronchoscopy , Cross Infection/epidemiology , Pneumonia, Bacterial/epidemiology , Ventilators, Mechanical/adverse effects , Anti-Bacterial Agents/therapeutic use , Bronchoalveolar Lavage , Bronchoscopes , Bronchoscopy/methods , Cohort Studies , Confidence Intervals , Critical Care , Enterobacteriaceae , Enterobacteriaceae Infections/epidemiology , Haemophilus Infections/epidemiology , Humans , Incidence , Logistic Models , Nose/microbiology , Odds Ratio , Oropharynx/microbiology , Pneumonia, Pneumococcal/epidemiology , Pneumonia, Staphylococcal/epidemiology , Positive-Pressure Respiration , Prospective Studies , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa , Risk Factors , Serum Albumin/analysis , Smoking/epidemiology , Stomach/microbiology , Tennessee/epidemiology , Time Factors , Trachea/microbiology , Ventilators, Mechanical/microbiology
6.
Clin Infect Dis ; 27(3): 463-70, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9770141

ABSTRACT

A prospective observational cohort study of nosocomial sinusitis was carried out in two medical intensive care units. Sinusitis was diagnosed by computed tomographic scanning and the culture of sinus fluid obtained by puncture of a maxillary sinus. Clinical and epidemiological data were collected at the time of admission to the unit and daily thereafter. Specimens from the nares, oropharynx, trachea, and stomach were cultured on admission and daily thereafter. The cumulative incidence of nosocomial sinusitis was 7.7%, and the incidence rates were 12 cases per 1,000 patient-days and 19.8 cases per 1,000 nasoenteric tube-days. Risk factors for nosocomial sinusitis, as determined by multiple logistic regression analysis, included nasal colonization with enteric gram-negative bacilli (odds ratio [OR], 6.4; 95% confidence interval [95% CI], 2.2-18.8; P = .007), feeding via nasoenteric tube (OR, 14.1; 95% CI, 1.7-117.6; P = .015), sedation (OR, 15.9; 95% CI, 1.9-133.5; P = .011), and a Glasgow coma score of < or = 7 (OR, 9.1; 95% CI, 3.0-27.3; P = .0001).


Subject(s)
Cross Infection/epidemiology , Intensive Care Units , Sinusitis/epidemiology , Cohort Studies , Cross Infection/diagnostic imaging , Cross Infection/microbiology , Humans , Incidence , Male , Middle Aged , Paranasal Sinuses/diagnostic imaging , Paranasal Sinuses/microbiology , Prospective Studies , Radiography , Risk Factors , Sinusitis/diagnostic imaging , Sinusitis/microbiology
7.
Am J Clin Nutr ; 68(3): 726-33, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9734754

ABSTRACT

We examined the cross-sectional association between intake of carotenoids with provitamin A activity and carotid artery plaques in 12,773 participants of the Atherosclerosis Risk in Communities Study aged 45-64 y. Usual diet was assessed with a 66-item food-frequency questionnaire. Plaques were examined by B-mode ultrasound of multiple carotid artery segments. In both women and men, those in the highest quintile of carotenoid consumption had a lower prevalence of plaques (women, 25.4%; men, 36.0%) than those in the lowest quintile of carotenoid consumption (women, 29.3%; men, 39.8%). The prevalence odds ratios contrasting extreme intake quintiles were 0.82 (95% CI: 0.70, 0.97) in women and 0.85 (95% CI: 0.72, 1.01) in men. The associations diminished slightly after potential confounders were adjusted for. In women, the inverse association was particularly strong for current smokers (adjusted odds ratio contrasting extreme quintiles: 0.67; 95% CI: 0.45, 0.98). In men, no such effect modification by smoking was seen. The inverse association was somewhat stronger in men aged 55-64 y than in those aged 45-54 y, whereas age made little difference in women. These findings, together with previous findings that carotenoid intake was unrelated to average carotid artery wall thickness, suggest that carotenoids may exert their influence later rather than earlier in the atherosclerotic process, and support the hypothesis that carotenoids or other plant-derived compounds may play a role in preventing arterial plaque formation.


Subject(s)
Arteriosclerosis/prevention & control , Carotenoids/administration & dosage , Carotid Arteries/pathology , Diet , Smoking/adverse effects , Arteriosclerosis/diagnostic imaging , Arteriosclerosis/epidemiology , Carotenoids/therapeutic use , Carotid Arteries/diagnostic imaging , Cross-Sectional Studies , Diet Surveys , Female , Humans , Male , Middle Aged , Prevalence , Prospective Studies , Risk Factors , Surveys and Questionnaires , Ultrasonography , United States/epidemiology
8.
Arch Otolaryngol Head Neck Surg ; 123(9): 978-81, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9305250

ABSTRACT

OBJECTIVE: To assess the incidence and magnitude of ototoxicity in patients undergoing an experimental targeted chemoradiation protocol incorporating extremely high-dose intra-arterial cisplatin therapy with systemic sodium thiosulfate neutralization for the treatment of advanced carcinomas of the head and neck. DESIGN: Inception cohort study. SETTING: University-based, tertiary care referral center for advanced head and neck malignant disease. PATIENTS: The first 70 patients with advanced carcinomas of the head and neck consecutively entered in the protocol. INTERVENTION: Patients received up to 4 weekly courses of intra-arterial cisplatin (150 mg/m2 per infusion), together with systemic sodium thiosulfate and external beam radiation (68-70 Gy). Audiometric analysis was performed before the initiation of therapy, and subsequent to the second and fourth cisplatin infusions. MAIN OUTCOME MEASURES: Audiometric thresholds. Ototoxicity was defined as an increase in pure-tone threshold of 15 dB at 1 frequency or 10 dB at 3 frequencies, between 250 and 4000 Hz. RESULTS: The incidence of ototoxicity was 25% at 150 mg/m2, 50% at 300 mg/m2, 64% at 450 mg/m2, and 60% at 600 mg/m2. Hearing at frequencies of 2000 Hz or less was minimally or not affected. Previous hearing loss did not appear to affect the incidence of ototoxicity. A plateau of hearing loss at 60-dB hearing level, as noted by other authors, was not observed. There were no cases of debilitating tinnitus or of vestibular loss. CONCLUSIONS: Ototoxicity did occur but was largely confirmed to the higher frequencies. Hearing losses resulting from this chemoradiation protocol were not sufficiently severe to alter its application.


Subject(s)
Antidotes/therapeutic use , Antineoplastic Agents/adverse effects , Carcinoma, Squamous Cell/drug therapy , Chelating Agents/therapeutic use , Cisplatin/adverse effects , Cochlea/drug effects , Head and Neck Neoplasms/drug therapy , Thiosulfates/therapeutic use , Adult , Antineoplastic Agents/administration & dosage , Audiometry, Pure-Tone , Auditory Threshold/drug effects , Carcinoma, Squamous Cell/radiotherapy , Cisplatin/administration & dosage , Cohort Studies , Combined Modality Therapy , Female , Follow-Up Studies , Head and Neck Neoplasms/radiotherapy , Hearing/drug effects , Hearing Disorders/physiopathology , Hearing Loss, High-Frequency/chemically induced , Humans , Incidence , Infusions, Intra-Arterial , Male , Middle Aged , Radiotherapy Dosage , Tinnitus/chemically induced , Vestibular Diseases/chemically induced
9.
Phys Med Biol ; 29(4): 385-94, 1984 Apr.
Article in English | MEDLINE | ID: mdl-6718490

ABSTRACT

Measurement of total body nitrogen is assuming increasing importance in the nutritional evaluation of seriously ill patients. Nitrogen has been previously measured either by counting (i) the annihilation radiation from 13N immediately after neutron irradiation with 14 MeV neutrons or (ii) the 'prompt' gamma rays from thermal neutron capture by 14N during irradiation with 14 MeV neutrons or with those produced by isotopic sources or a cyclotron. The present work describes studies into the feasibility of measuring 13N produced by irradiation with a neutron beam from the MRC Cyclotron. A complication of this method is that 13N is also produced in a reaction with 16O. Direct measurement of oxygen by use of the reactions 16O(n, p)16N or 16O(n, 2n)15O enables this interference to be estimated. The former reaction is possible with both 14 meV and cyclotron-produced neutrons but the 7.1 s half-life of 16N requires detectors to be placed in or very close to the irradiation site. In our particular circumstances this is not possible but the more energetic cyclotron neutron spectrum allows the production of 15O which has a half-life of 2.05 min and can be measured in a remote whole-body counter. A disadvantage with the cyclotron beam, in comparison with 14 MeV neutrons, is that a higher dose is required for similar accuracy. A reproducibility of about 4% is obtained with a dose equivalent of 0.01 Sv.


Subject(s)
Body Composition , Nitrogen/analysis , Oxygen/analysis , Humans , Methods , Neutrons , Particle Accelerators , Radiometry/instrumentation
SELECTION OF CITATIONS
SEARCH DETAIL
...